Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Plos One|August 13, 2013
Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson's diseaseKatrina L Paumier, Stacey J Sukoff Rizzo, Zdenek Berger, et al.Movement Disorders : Official Journal of the Movement Disorder Society|December 13, 2025
LRRK2 as a Potential Disease-Modifying Target in Sporadic Parkinson's DiseaseAnthony E Lang, Robert A Hauser, Lorraine V Kalia, et al.Bioorganic & Medicinal Chemistry Letters|August 13, 2014
Kinase domain inhibition of leucine rich repeat kinase 2 (LRRK2) using a [1,2,4]triazolo[4,3-b]pyridazine scaffoldPaul Galatsis, Jaclyn L Henderson, Bethany L Kormos, et al.Advances in Therapy|May 9, 2024
A Post-Marketing Surveillance Study of Nusinersen for Spinal Muscular Atrophy in Routine Medical Practice in China: Interim ResultsYuwu Jiang, Yi Wang, Hui Xiong, et al.Journal of Medicinal Chemistry|October 30, 2014
Discovery and preclinical profiling of 3-[4-(morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), a highly potent, selective, brain penetrant, and in vivo active LRRK2 kinase inhibitorJaclyn L Henderson, Bethany L Kormos, Matthew M Hayward, et al.Nature|July 25, 2006
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17Matt Baker, Ian R Mackenzie, Stuart M Pickering-Brown, et al.Muscle & Nerve|July 6, 2023
Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5-year update of the NURTURE studyThomas O Crawford, Kathryn J Swoboda, Darryl C De Vivo, et al.Pageof 3